GENE ONLINE|News &
Aggressive LDL-C Lowering Strategies and Statin Therapy Contraindications Emphasized by Experts.
Experts say that initiating statin therapy necessitates careful evaluation of contraindications and individual patient characteristics. They also state that treatment approaches are shifting towards more aggressive strategies for lowering low-density lipoprotein cholesterol (LDL-C), guided by personalized risk assessments. The panelists emphasized that factors such as liver disease, renal impairment, and advanced age require particular consideration when determining the appropriateness of statin therapy. Furthermore, evolving treatment patterns reflect a move toward more intensive LDL-C lowering, tailoring therapeutic interventions to each patient’s specific risk profile.
Newsflash | Powered by GeneOnline AI
Date: April 28, 2025
Author
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
